Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Pulmonary Fibrosis

erlotinib hydrochloride has been researched along with Pulmonary Fibrosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davidson, CR; Hardie, WD; Ikegami, M; Korfhagen, TR; Le Cras, TD; Schmidt, SM; Whitsett, JA1
Adachi, K; Chiba, S; Deki, T; Kawarada, S; Miyoshi, A; Mizoguchi, K; Suzuki, M1
Le Chevalier, T; Tsuboi, M1
Bach, JP; Faoro, C; Gorg, C; Kiessling, AM; Kleinhans, A; Neubauer, A; Riera-Knorrenschild, J; Schwella, N; Wagner, HJ1
Davidson, C; Hardie, WD; Ikegami, M; Korfhagen, TR; Le Cras, TD; Leikauf, GD; Prestridge, A; Whitsett, JA1

Other Studies

5 other study(ies) available for erlotinib hydrochloride and Pulmonary Fibrosis

ArticleYear
Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis.
    American journal of respiratory cell and molecular biology, 2009, Volume: 41, Issue:5

    Topics: Animals; Carrier Proteins; Collagen; Disease Models, Animal; Disease Progression; Doxycycline; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression Regulation; Humans; Lung; Mice; Mice, Transgenic; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Quinazolines; Respiratory Mechanics; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Transforming Growth Factor alpha; Uteroglobin

2009
Effects of erlotinib on lung injury induced by intratracheal administration of bleomycin (BLM) in rats.
    The Journal of toxicological sciences, 2010, Volume: 35, Issue:4

    Topics: Animals; Bleomycin; Dogs; Erlotinib Hydrochloride; Humans; Hydroxyproline; Injections; Lung; Lung Injury; Neutrophils; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Rats; Trachea

2010
Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors.
    Medical oncology (Northwood, London, England), 2006, Volume: 23, Issue:2

    Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Incidence; Japan; Lung Neoplasms; Male; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Risk Factors

2006
Pulmonary fibrosis in a patient treated with erlotinib.
    Onkologie, 2006, Volume: 29, Issue:7

    Topics: Adult; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines

2006
EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis.
    American journal of physiology. Lung cellular and molecular physiology, 2008, Volume: 294, Issue:6

    Topics: Animals; Bronchoalveolar Lavage Fluid; Doxycycline; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Gene Expression; Humans; Mice; Pulmonary Fibrosis; Quinazolines; RNA, Messenger; Transforming Growth Factor alpha

2008